Literature DB >> 21430830

Recurrent dermatofibrosarcoma protuberans over anterior abdominal wall.

Ashok Y Kshirsagar1, Sujata R Kanetkar, Yogesh P Nikam, Gaurav Op Vasisth.   

Abstract

A 45-year-old female complained of a painless swelling, which had developed in the epigastric region, and was slowly growing in size over the last one year. The patient had undergone excision of a similar swelling at the same site seven years ago and was now facing recurrence. Histopathology and immunohistochemical (IHC) examination confirmed the diagnosis of Dermatofibrosarcoma Protuberans.

Entities:  

Keywords:  Anterior abdominal wall; dermatofibrosarcoma protuberans; recurrence

Year:  2010        PMID: 21430830      PMCID: PMC3047735          DOI: 10.4103/0974-2077.74494

Source DB:  PubMed          Journal:  J Cutan Aesthet Surg        ISSN: 0974-2077


INTRODUCTION

The most common soft tissue tumour of the abdominal wall is the desmoid tumour while the least frequent is the Dermatofibrosarcoma Protuberans.[1] Dermatofibrosarcoma Protuberans (DFSP) is a rare, indolent, low-grade sarcoma recognised for its progressive locally infiltrative nature. A painless, long-standing, slow-growing subcutaneous nodule remains its most common form of presentation of this disease. It constitutes less than 0.1% of all cutaneous malignancies and 6% of all soft tissue sarcomas. The incidence has been estimated at 0.8 cases per million persons per year.[2] Metastasis is rare but if it occurs almost all metastatic cases have been associated with local recurrence and a poor prognosis. Early diagnosis, wide excision and regular follow-up are indicated for DFSP.

CASE REPORT

A 45-year-old female came to the hospital with chief complaints of recurrent swelling in the epigastric region since one year. The swelling was initially small in size, nodular gradually increasing in size and had currently achieved the dimensions of about 5 × 5 cm [Figure 1].
Figure 1

Skin colored nodule covered with hemorrhagic scab present over the scar of previous excision on abdomen

Skin colored nodule covered with hemorrhagic scab present over the scar of previous excision on abdomen The swelling, which was earlier painless, had now become painful after it ruptured with a bloody discharge. The skin around the swelling was retracted and shriveled in appearance, which was consistent with past history of wide excision with split thickness skin grafting seven years back. Clinical parameters were within normal limits. Chest roentgenogram was normal. With the provisional diagnosis of recurrent DFSP the patient was taken up for surgery. The patient underwent a wide local excision of the mass. The tumour involved rectus sheath, rectus sheath and part of rectus muscle with margin of 2.5 cm was removed. Same margin of 2.5 cm was taken in all directions [Figure 2]. The defect was covered with split thickness skin grafting. No intra-abdominal extension of the tumour was found.
Figure 2

Clinical picture of post-op scar resulting from wide excision of tumour with split thickness skin grafting

Clinical picture of post-op scar resulting from wide excision of tumour with split thickness skin grafting Microscopic examination revealed elongated spindle-shaped cells arranged in sheets, tiny nodules, storiform pattern with pleomorphic, hyperchromatic or vesicular nuclei with 2-4 prominent nucleoli and moderate amount of eosinophilic cytoplasm mixed with histiocytes Figure 3. The pathological diagnosis was DFSP, which was confirmed by immuno-histochemical examination. Immunohistochemistry showed that tumour cells were positive for CD34 and XIIIa.
Figure 3

Histopathology of the tumour reveals spindle shaped cells arranged in storiform pattern

Histopathology of the tumour reveals spindle shaped cells arranged in storiform pattern Recovery was uneventful and patient was discharged on the fifth post-operative day. Patient is asymptomatic one year after surgery and is coming for regular follow-up.

DISCUSSION

Soft tissue sarcomas are mesenchymal neoplasms comprising 1% of adult malignant tumours. Among the soft tissue tumours, abdominal wall tumours are uncommon, accounting for less than 5% of these neoplasms.[34] Historically, this neoplasm was first described by Taylor, in 1890, but Hoffman coined the currently accepted term when he reported three cases in 1925.[3] Chromosomes 17 and 22 has been incriminated in the aetiopathogenesis of DFSP. There is translocation t(17:22) involving COL1A1 (collagen type 1α1 gene) and PDGF β (platelet-derived growth factor) genes respectively.[56] The tumour first appears as a single, red to bluish, blanchable, firm, cutaneous nodule. During the late stage, rate of growth accelerates, producing the characteristic protrusion from the skin.[7] The growth rate is variable. Lesions may remain stable for many years or they may grow slowly with periods of accelerated growth. Local recurrences occur in 20-55% cases.[7] There are conditions that can mimic DFSP, which should be considered in the differential diagnosis. They are: dermatofibroma, epidermal inclusion cyst, keloid and hypertrophic scar, malignant melanoma and metastatic carcinoma of the skin. Computerised tomography (CT) or magnetic resonance imaging (MRI) have been indicated to stage these tumours. These imaging techniques are important for planning of resection.[3] Essentially, the optimal treatment for DSFP has been a wide resection. Since these tumours are locally infiltrative, treatment follows the general principles of soft tissue sarcoma management with adequate excision and adjuvant radiotherapy when appropriate, with or without adjuvant chemotherapy. A three-dimensional wide resection of skin and surrounding structures must be performed. Most authors recommend a 2-3 cm local margin including the underlying deep fascia and overlying skin.[3] Imatinib has shown clinical activity against both localised and metastatic DFSP with t(17;22). However, fibrosarcomatous variants of DFSP lacking t(17;22) may not respond to imatinib.[8] Adjuvant treatment with radiotherapy seems controversial. There are specialised services that have recommended adjuvant radiotherapy for large low-grade (>5 cm) or high-grade sarcomas.[3]
  7 in total

1.  Staging of soft tissue sarcomas.

Authors:  M F Brennan
Journal:  Ann Surg Oncol       Date:  1999 Jan-Feb       Impact factor: 5.344

2.  Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans.

Authors:  S Kiuru-Kuhlefelt; W El-Rifai; J Fanburg-Smith; J Kere; M Miettinen; S Knuutila
Journal:  Cytogenet Cell Genet       Date:  2001

3.  Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

Authors:  T Sjöblom; A Shimizu; K P O'Brien; K Pietras; P Dal Cin; E Buchdunger; J P Dumanski; A Ostman; C H Heldin
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

4.  Dermatofibrosarcoma protuberans: an analysis of 86 cases--five with metastasis.

Authors:  C J McPeak; T Cruz; A D Nicastri
Journal:  Ann Surg       Date:  1967-11       Impact factor: 12.969

5.  Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

Authors:  Grant A McArthur; George D Demetri; Allan van Oosterom; Michael C Heinrich; Maria Debiec-Rychter; Christopher L Corless; Zariana Nikolova; Sasa Dimitrijevic; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

6.  Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment.

Authors:  A Stojadinovic; A Hoos; H M Karpoff; D H Leung; C R Antonescu; M F Brennan; J J Lewis
Journal:  Arch Surg       Date:  2001-01

7.  Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment.

Authors:  Vijay P Khatri; Joseph M Galante; Richard J Bold; Philip D Schneider; Rajendra Ramsamooj; James E Goodnight
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

  7 in total
  1 in total

1.  Recurrent dermatofibrosarcoma protuberans: A continuing problem.

Authors:  Manisha Makkar; Dayal Pratap Singh; Akshay Rana; Mayank Madan
Journal:  Indian Dermatol Online J       Date:  2013-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.